Foghorn Therapeutics Inc. (FHTX)
4.19
-0.05 (-1.18%)
At close: Jan 15, 2025, 9:39 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | 34.16M | 19.23M | 1.32M | 430.00K | n/a | n/a |
| Cost of Revenue | 109.69M | 19.23K | 7.51M | 57.72M | 1.79M | 379.00K |
| Gross Profit | -75.53M | 19.21M | -6.20M | -57.28M | -1.79M | -379.00K |
| Operating Income | -107.91M | -117.14M | -100.73M | -68.53M | -51.08M | -26.05M |
| Interest Income | 10.88M | 5.67M | 2.55M | 1.00M | 495.00K | 113.00K |
| Pretax Income | -94.20M | -108.88M | -101.32M | -68.80M | -51.13M | -26.34M |
| Net Income | -98.43M | -108.87M | -103.23M | -69.78M | -51.67M | -26.34M |
| Selling & General & Admin | 32.37M | 30.75M | 21.73M | 11.25M | 6.72M | 4.82M |
| Research & Development | 109.69M | 105.62M | 80.33M | 57.72M | 44.36M | 21.23M |
| Other Expenses | n/a | 8.26M | 2.49M | n/a | n/a | n/a |
| Operating Expenses | 142.06M | 136.37M | 102.05M | 68.96M | 51.08M | 26.05M |
| Interest Expense | n/a | n/a | 1.91M | 979.00K | 540.00K | 371.00K |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 142.06M | 136.37M | 102.05M | 68.96M | 51.08M | 26.05M |
| Income Tax | 4.23M | -8.26K | 1.91M | 979.00K | 540.00K | 83.00K |
| Shares Outstanding (Basic) | 41.97M | 41.59M | 37.17M | 36.79M | 36.82M | 19.63M |
| Shares Outstanding (Diluted) | 41.97M | 41.59M | 37.17M | 36.79M | 36.82M | 19.63M |
| EPS (Basic) | -2.34 | -2.62 | -2.78 | -1.9 | -1.4 | -1.34 |
| EPS (Diluted) | -2.34 | -2.62 | -2.78 | -1.9 | -1.4 | -1.34 |
| EBITDA | -104.45M | -113.82M | -96.19M | -66.49M | -48.80M | -25.59M |
| Depreciation & Amortization | 3.45M | 7.90M | 7.51M | 5.53M | 1.79M | 379.00K |